A Inenarrável Corrupção da Profissão Médica

Drug firms paid £40m to UK doctors in 2012. The Association of the British Pharmaceutical Industry tallied figures from 18 of the 20 largest drug companies among its members for payments covering sponsorship and consultancy and speaking fees to healthcare professionals in the UK. The figures will rekindle the debate over the potential for conflicts of interest in drug companies influencing prescribing practices. Industry critics arguing that some medicines are given more widely than is justified by efficacy and safety data.